Abstract Purpose of Review This review aims to provide an overview of neuroinflammation
in ischemic and hemorrhagic stroke, including recent findings on the mechanisms and …

Following a cerebral ischemic event, substantial alterations in both cellular and molecular
activities occur due to ischemia-induced cerebral pathology. Mounting evidence indicates …

Stroke, a neurological disease, is one of the leading causes of death worldwide, resulting in
long-term disability in most survivors. Annual stroke costs in the United States alone were …

Stroke is a threatening cerebrovascular disease caused by thrombus with high morbidity
and mortality rates. Neutrophils are the first to be recruited in the brain after stroke, which …

Stroke is one of the major causes of death and severe disability worldwide. At present,
intravenous thrombolysis to restore blood flow at the ischemic part of the brain is the main …

Stroke is the second leading cause of death worldwide; however, the treatment choices
available to neurologists are limited in clinical practice. Lipocalin 2 (LCN2) is a secreted …

Venous thromboembolism (VTE) is the third leading cardiovascular cause of death and is
conventionally treated with anticoagulants that directly antagonize coagulation. However …

Stroke is the second leading cause of death globally and the major cause of long-term
disability. Among the types of strokes, ischemic stroke, which occurs due to obstruction of …

Nanocarriers (NCs) are widely explored in the development of anti-tumor therapeutics. NCs
offer many advantages over conventional drug delivery systems (DDS) such as improved …

Abstract Aims Neutrophil extracellular traps (NETs) have been implicated in thrombotic
diseases. There is no definitive explanation for how NETs form during acute ischemic …